Heartflow (HTFL) EV to EBITDA (2025 - 2026)
Heartflow (HTFL) posted EV to EBITDA of 121.19 for Q2 2026, down 139.68% on a QoQ basis from 50.56 in Q4 2025.
Powered by 
Analysis
Heartflow (HTFL) EV to EBITDA (2025 - 2026) Analysis & Trends
Heartflow has reported EV to EBITDA for 2 years, with the latest figure at 121.19 in Q2 2026.
- On a quarterly basis, EV to EBITDA changed N/A year-over-year to 121.19 in Q2 2026; TTM through Jun 2026 was 33.65, a N/A change from a year earlier, with the FY2025 full-year figure at 14.01, changed N/A from the prior year.
- EV to EBITDA was 121.19 for Q2 2026 at Heartflow, down from 50.56 in the prior quarter.
- The five-year high for EV to EBITDA was 50.56 in Q4 2025, with the low at 121.19 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -121.19 |
| Dec 31, 2025 | -50.56 |
| Sep 30, 2025 | -90.19 |